AGE – Contribution to the revision of the clinical trials directive

11 May 2011

The European Commission is planning to put forward, in 2012, a legislative proposal to revise the Clinical Trials Directive 2001/20/EC.

Considering the recent development regarding geriatric medicines, particular the decision made by the European Medicine Agency (EMA) in February 2011 to launch a geriatric medicines strategy, AGE Platform Europe considered this revision of the directive has an opportunity to support this new strategy and decided to focus its contribution on the need to improve participation of older people in clinical trials of medicines commonly used for geriatric patients.

The contribution is available here: WORD Format, PDF Format

Additional information:

EMA Webpages of geriatric medicines

European Commission Webpage on clinical trials

Related news

our Publications

AGE Barometer

AGE Barometer assesses on a bi-annual basis the socio-economic situation of older people across the EU and how this situation...
External Resources

Connecting healthy ageing and vision

The report Connecting Healthy Ageing and Vision, released on World Sight Day by The Fred Hollows Foundation and the International...

View all

Contact us

Avenue de Tervueren, 168/2
1150 Brussels, Belgium

Tel.: +32 (0)2 280 14 70
info@age-platform.eu

Subscribe to our Newsletter

Hidden
This field is for validation purposes and should be left unchanged.

AGE is a member of

Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them. Transparency Register ID: 16549972091-86

Skip to content